SBIR-STTR Award

  1. You are here:    Home
  2. Search Databases
  3. Search SBIR-STTR Awards
  4. SBIR-STTR Award

Development of a Rapid and Scalable Method for Bacteriophage Manufacture and Purification
Award last edited on: 2/26/2023

Sponsored Program
SBIR
Awarding Agency
NIH : NIAID
Total Award Amount
$296,787
Award Phase
1
Solicitation Topic Code
95
Principal Investigator
Subhendu Basu

Company Information

Adaptive Phage Therapeutics Inc (AKA: APT)

708 Quince Orchard Road Suite 205
Gaithersburg, MD 20878
   (844) 972-0500
   info@aphage.com
   www.aphage.com
Location: Single
Congr. District: 06
County: Montgomery

Phase I

Contract Number: 75N93021C00032
Start Date: 8/16/2021    Completed: 8/15/2022
Phase I year
2021
Phase I Amount
$296,787
Development of a Rapid and Scalable Method for Bacteriophage Manufacture and Purification.

Public Health Relevance Statement:


Project Terms:
Phages, bacterial virus, Bacteriophages, Gram-Negative Bacteria, Methods, Antimicrobial Resistance, Antimicrobial resistant, Resistance to antimicrobial, anti-microbial resistance, anti-microbial resistant, resistance to anti-microbial, resistant to anti-microbial, resistant to antimicrobial, Small Business Innovation Research Grant, SBIR, Small Business Innovation Research, Development, developmental, therapeutic development, therapeutic agent development

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----